Evidence map›Paper›PMID 25776526›Full record

ArticleJournal of neurovirology2015

Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.

Jennifer L McGuire, Alexander J Gill, Steven D Douglas, Dennis L Kolson, CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) group

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 3 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jennifer L McGuireDivision of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA, mcguirej@email.chop.edu.
Alexander J Gill
Steven D Douglas
Dennis L Kolson
CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) group
University of Pennsylvania · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Penn Mental Health AIDS Research CenterP30MH097488 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Knashawn Hodge Morales · 2013 to 2026
$23.5M
Adolescent Trials Unit at The Children's Hospital of PhiladelphiaU01HD040481 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI DOUGLAS, STEVEN DANIEL · 2001 to 2015
$11.4M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
TACHYKININS, MONONUCLEAR PHAGOCYTES, AND HIV1 INFECTIONR01MH049981 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI DOUGLAS, STEVEN DANIEL · 1995 to 2012
$5.8M
Project 5U01MH090325 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI DOUGLAS, STEVEN DANIEL · 2009 to 2013
$5.6M
NSADA Training Grant for Child NeurologistsK12NS049453 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI TENNEKOON, GIHAN I · 2006 to 2015
$4.4M
Project 3: Targeting Neurokinin 1 ReceptorP01MH105303 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI DOUGLAS, STEVEN DANIEL · 2014 to 2017
$4.3M
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotectionR01MH095671 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ALDOVINI, ANNA, KOLSON, DENNIS LARRY · 2011 to 2015
$3.5M
Philadelphia IMPAACT Clinical Trials UnitUM1AI069467 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI DOUGLAS, STEVEN DANIEL · 2012 to 2014
$3.1M
Oxidative Stress, Immune Activation, and Therapeutic Targeting in HIV/HANDR01MH104134 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KOLSON, DENNIS LARRY · 2014 to 2018
$2.3M
Heme Oxygenase-1 as a novel therapeutic target in HIV-mediated neurodegenerationF30MH102120 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GILL, ALEXANDER J · 2014 to 2016
$106k
NIAID NIH HHS P30 AI045008NIAID NIH HHS R21-AI108298NIAID NIH HHS T32 AI007632NIAID NIH HHS T32-AI007632NIAID NIH HHS UM1 AI069467NIAID NIH HHS UM1-AI69467NICHD NIH HHS 5UO1-HD040481NICHD NIH HHS U01 HD040481NIMH NIH HHS 1U01-MH090325NIMH NIH HHS F30 MH102120NIMH NIH HHS F30-MH102120NIMH NIH HHS N01 MH022005NIMH NIH HHS P01 MH105303NIMH NIH HHS P01-MH105303NIMH NIH HHS P30 MH097488NIMH NIH HHS P30-MH097488NIMH NIH HHS R01 MH049981NIMH NIH HHS R01-MH049981NIMH NIH HHS R01 MH095671NIMH NIH HHS R01-MH095671NIMH NIH HHS R01 MH104134NIMH NIH HHS R01-MH104134NIMH NIH HHS U01 MH090325NINDS NIH HHS K12 NS049453NINDS NIH HHS K12-NS049453
6 · The paper itself

Abstract

HIV-associated neurocognitive disorders (HAND) affect up to 50 % of HIV-infected adults, independently predict HIV morbidity/mortality, and are associated with neuronal damage and monocyte activation. Cerebrospinal fluid (CSF) neurofilament subunits (NFL, pNFH) are sensitive surrogate markers of neuronal damage in several neurodegenerative diseases. In HIV, CSF NFL is elevated in individuals with and without cognitive impairment, suggesting early/persistent neuronal injury during HIV infection. Although individuals with severe cognitive impairment (HIV-associated dementia (HAD)) express higher CSF NFL levels than cognitively normal HIV-infected individuals, the relationships between severity of cognitive impairment, monocyte activation, neurofilament expression, and systemic infection are unclear. We performed a retrospective cross-sectional study of 48 HIV-infected adults with varying levels of cognitive impairment, not receiving antiretroviral therapy (ART), enrolled in the CNS Anti-Retroviral Therapy Effects Research (CHARTER) study. We quantified NFL, pNFH, and monocyte activation markers (sCD14/sCD163) in paired CSF/plasma samples. By examining subjects off ART, these correlations are not confounded by possible effects of ART on inflammation and neurodegeneration. We found that CSF NFL levels were elevated in individuals with HAD compared to cognitively normal or mildly impaired individuals with CD4+ T-lymphocyte nadirs ≤200. In addition, CSF NFL levels were significantly positively correlated to plasma HIV-1 RNA viral load and negatively correlated to plasma CD4+ T-lymphocyte count, suggesting a link between neuronal injury and systemic HIV infection. Finally, CSF NFL was significantly positively correlated with CSF pNFH, sCD163, and sCD14, demonstrating that monocyte activation within the CNS compartment is directly associated with neuronal injury at all stages of HAND.

Indexed as

AdultAIDS Dementia ComplexBiomarkersCross-Sectional StudiesFemaleHumansMacrophage ActivationMaleMiddle AgedMonocytesNerve DegenerationNeurofilament ProteinsNeuropsychological TestsRetrospective StudiesBiomarkersNeurofilament Proteins

Identifiers

PMID25776526
PMCPMC4511078
OpenAlexW2009336580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.